FindTrial
Sign In

Short-term endpoints of conventional versus totally thoracoscopic surgery in patients with mitral valve replacement: one centre, randomised controlled trial

Short-term endpoints of conventional versus totally thoracoscopic surgery in patients with mitral valve replacement: one centre, randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001396
Enrollment
Unknown
Registered
2011-06-13
Start date
2011-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mitral valve disease

Interventions

A:conventional sternotomy for MVR
B:thoracoscopy

Sponsors

Xijing Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients must have a diagnosis of mitral valve disease, either stenosis or regurgitation or both, be suitable for elective surgical MVR

Exclusion criteria

Exclusion criteria: Patients are not eligible if they need emergency surgery or secondary surgery or combined other cardiac surgery.Patients with aortic valve disease, coronary heart disease, a contraindication of thoracoscopy, acute pulmonary infection, or other associated pulmonary pathology are not eligible either.

Design outcomes

Primary

MeasureTime frame
new stroke;low output syndrome, LOS;paravalvular leak;all cause mortality;—

Secondary

MeasureTime frame
postoperative infection;more blood transfusion;acute renal failure;reoperation;hours on the ventilator;days in intensive care;postoperative hospital stay;—

Countries

China

Contacts

Public ContactQin Cui
13809186551@126.com+86 13809186551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026